Skip to content
Krv Labs
News

(From the Lab)

Milestones, publications, and updates from the Krv team.

2026

Erdos + Renyi: a new product line for fully local trial intelligence

We're building a new Erdos and Renyi product line for clinical trial intelligence and patient recruitment that runs fully on a site's own machines. The names are inspired by the mathematicians Paul Erdős and Alfréd Rényi, and by their pioneering work on random graphs. Patient records never leave the site. Updates coming soon.

Krv Labs

Topos v0.14.0: faster reviews for agent-written code

Ten minor releases since v0.4.0 in July. Scores are now anchored to quality gates with advisories relative to your own codebase, Topos ships as a portable Agent Plugins 1.0 package, and v0.14.0 shares dependency graphs and reuses analysis so repeated MCP assessments run faster on less memory.

GitHub

Jeremy Wayland defends his PhD, magna cum laude

Krv co-founder Jeremy Wayland defended his TUM dissertation, "Understanding Data Representations using Geometry and Topology", and was awarded magna cum laude.

Krv Labs

Krv starts building Phirewall

Phirewall is a local PHI vault and MCP gateway: AI assistants can analyze patient records while names, record numbers and birth dates stay on the clinician's machine as codes. It fails closed and has no servers of its own. Coming soon for Mac and Windows.

Krv Labs

Krv Labs, Inc. incorporates as a Delaware C-Corp

Krv Labs is now Krv Labs, Inc., a Delaware C-corporation.

Krv Labs

Working from Madiba's offices in Lake Forest

The team spent the summer working out of Madiba's offices in Lake Forest, California. Thanks to Madiba for hosting us.

Krv Labs

Krv Labs launches Topos v0.3.0

Quality is the new currency for agent-written code. Topos v0.3.0 is the first proper release of open-source structural quality metrics for coding agents—scoring whether diffs are built to last, not just whether they pass tests. Evaluates whether programs are SIMPLE, COMPOSABLE, and SECURE. Currently supports code written in Python, Rust, C++, TypeScript, and JavaScript.


Krv begins working with pharma sponsors

Conversations at the International Pediatric and Lifespan Data Science Conference, after our podium talk, led to our first work with a pharmaceutical sponsor. We model a trial's target patients, and each site finds candidates in its own records, locally. Investigators review every candidate; Krv never sees the patients.

Krv Labs

PhD Dissertation submitted to TUM CIT!

J. Wayland submits cumulative dissertation titled: "Understanding Data Representations using Geometry and Topology"

Krv Labs

Krv website updated to reflect new vision: Clinical trials for AI models

Website updated to showcase Krv's focus on improving evaluations and reliability for clinical AI deployments.

Krv Labs

2025

Krv joins Berkeley SkyDeck’s Pad 13 accelerator program

Berkeley SkyDeck

Krv accepted as affiliate to TUM Venture Labs Healthcare

TUM Venture Labs Healthcare

Krv accepted into Neo4j Startup Program

Neo4j

J. Wayland attends YC AI Startup School in San Francisco

Y Combinator

Decision to Accept from Nature Energy reviewers

Krv team and collaborators are notified of acceptance decision.

Nature Energy